Over 70 and Never Had a Heart Attack
New statin research may change the conversation
The important caution comes first: this study is not a reason for every older adult to begin a statin. It is a strong reason for some adults over 70 to revisit the question with their healthcare provider.
For years, physicians have had limited randomized-trial evidence about whether otherwise healthy adults should start cholesterol-lowering medication after age 70. A major study published August 29, 2026, in the New England Journal of Medicine helps fill that gap.
What the researchers discovered
The STAREE trial included 9,971 community-dwelling Australians age 70 and older who had no history of cardiovascular disease, diabetes, or dementia. Participants were randomly assigned to take either 40 mg of atorvastatin each day or a placebo and were followed for a median of 5.9 years.
| 30% lower risk of a first major cardiovascular event |
37 people treated for nearly six years to prevent one event |
5.9 years median follow-up in the trial |
Compared with placebo, atorvastatin reduced the risk of a first major cardiovascular event, including heart attack, stroke, cardiovascular death, or a coronary procedure. Researchers recorded 297 events in the statin group and 412 in the placebo group.
What the medication did not do
The medication did not significantly extend disability-free survival. Participants taking atorvastatin did not live significantly longer without death, dementia, or persistent physical disability. Serious adverse events were similar between the groups.
The evidence supports fewer cardiovascular events among the people studied. It does not establish that statins help every older adult live longer, prevent dementia, or remain independent.
Who might be affected
The findings apply most directly to relatively healthy, independently living adults age 70 or older who have not previously experienced cardiovascular disease and do not have diabetes or dementia.
Important limitation: the trial does not directly answer the same question for people who are frail, have significant cognitive impairment, live with multiple complex illnesses, or have a limited life expectancy. Participants were also almost entirely White and lived in Australia, which may limit how broadly the findings apply.
CAYCARE COMMUNITY HEALTH NEWSLETTER
Do not start or stop a statin on your own
A treatment decision should consider more than age or one cholesterol number. A clinician should review the person’s cardiovascular risk, current medications, possible interactions, health goals, life expectancy, and willingness to take a daily medication.
For some healthy adults over 70, preventing a first heart attack or stroke may outweigh the inconvenience or possible side effects of another medication. For someone experiencing frailty, medication burden, muscle symptoms, or advanced illness, the balance may look different.
Questions to take to the next appointment
- What is my personal risk of having a heart attack or stroke?
- Would the people studied in this trial be considered similar to me?
- How much might a statin reduce my individual risk?
- Could it interact with my current medications?
- What side effects should I report?
- When would we reconsider whether I should continue taking it?
- Does this treatment fit my health priorities and long-term goals?
Bring an updated medication and supplement list. If several specialists prescribe medications, ask who will monitor the complete plan.
What you can do now
- Do not change cholesterol medication without medical guidance.
- Schedule a medication and cardiovascular-risk review if you are over 70 and unsure whether a statin is appropriate.
- Ask for the potential benefit in understandable terms: “Out of 100 people like me, how many might avoid a heart attack or stroke?”
- Discuss blood pressure, smoking, physical activity, nutrition, and diabetes screening alongside medication.
- Share the plan with the person who helps manage appointments or prescriptions.
The larger lesson
Older adults are often treated using research conducted in younger populations. This large randomized trial provides stronger age-specific evidence, but good care still requires an individualized decision—not a one-size-fits-all message.
Churches, senior centers, and senior living communities can help by encouraging medication reviews and informed conversations while leaving prescribing decisions to qualified clinicians.
CayCare helps families organize questions, understand care instructions, and keep the practical pieces of an older adult’s health plan from becoming disconnected. Sometimes the most valuable support is ensuring the right conversation happens with the right professional.
Sources
New England Journal of Medicine study • PubMed abstract • Monash University summary
Medical information notice: This article is for general education and does not replace individualized medical advice. Medication decisions should be made with a physician, pharmacist, or other qualified healthcare professional.